|
LINS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.20166115841403E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.77080050412349E-10 |
| Normal-vs-Stage2 |
1.57402999999556E-05 |
| Normal-vs-Stage3 |
1.86339832453086E-12 |
| Normal-vs-Stage4 |
6.96365187735637E-12 |
| Stage1-vs-Stage2 |
9.688600E-01 |
| Stage1-vs-Stage3 |
2.111700E-02 |
| Stage1-vs-Stage4 |
4.783500E-03 |
| Stage2-vs-Stage3 |
1.197560E-01 |
| Stage2-vs-Stage4 |
5.346000E-02 |
| Stage3-vs-Stage4 |
5.031400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.96969132512959E-12 |
| Normal-vs-AfricanAmerican |
9.121400E-03 |
| Normal-vs-Asian |
6.97309998631823E-09 |
| Caucasian-vs-AfricanAmerican |
5.238000E-02 |
| Caucasian-vs-Asian |
3.619200E-01 |
| AfricanAmerican-vs-Asian |
2.530100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.52659999986105E-07 |
| Normal-vs-Female |
1.67454938804212E-12 |
| Male-vs-Female |
5.843600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.70430044813486E-10 |
| Normal-vs-Age(41-60Yrs) |
7.52939932624486E-11 |
| Normal-vs-Age(61-80Yrs) |
2.3202995080851E-10 |
| Normal-vs-Age(81-100Yrs) |
3.922200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.343440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.219590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.796200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.210800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.497000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.703400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.57135999999669E-05 |
| Classical-VS-Follicular |
5.935800E-01 |
| Classical-VS-Other |
1.604760E-01 |
| Classical-VS-Normal |
1.76719971989314E-10 |
| Tall-VS-Follicular |
1.739520E-03 |
| Tall-VS-Other |
6.245000E-01 |
| Tall-VS-Normal |
1.00475183728577E-13 |
| Follicular-VS-Other |
3.383000E-01 |
| Follicular-VS-Normal |
3.76899999987579E-07 |
| Other-VS-Normal |
3.038400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.53037607428541E-12 |
| Normal-vs-N1 |
2.9789000155489E-09 |
| N0-vs-N1 |
5.027800E-01 |
|
|
